Picture of Cytosorbents logo

CTSO Cytosorbents Balance Sheet

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Annual balance sheet for Cytosorbents, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Cash and Equivalents
Cash and Short Term Investments12.271.452.122.114.1
Net Total Accounts Receivable
Net Total Receivables4.475.164.525.666.06
Total Inventory
Prepaid Expenses
Total Current Assets20.982.564.333.825.7
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment33.1518.623.322.1
Net Intangible Assets
Other Long Term Assets
Total Assets27.49089.563.253.3
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities9.9410.213.79.7114.5
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities2410.726.927.930
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity3.4279.262.635.423.3
Total Liabilities & Shareholders' Equity27.49089.563.253.3
Total Common Shares Outstanding